Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant

被引：0
|
作者：
Grace Chen
Ronald Lee
Astrid-Maria Højer
Jeppe Klint Buchbjerg
Michael Serenko
Zhen Zhao
机构：
[1] Takeda Development Center Americas,Clinical Pharmacology
[2] H. Lundbeck A/S,Pharmacovigilance
[3] Takeda Development Center Americas,Statistics
[4] Takeda Development Center Americas,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Omeprazole; Fluconazole; Ketoconazole; Bupropion; Major Depressive Disorder Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：727 / 736
页数：9
相关论文
共 50 条
  • [21] Long-term safety and tolerability of the multimodal antidepressant Lu AA21004 in subjects with major depressive disorder
    Alam, M.
    Jacobsen, P. L.
    Chen, Y.
    Serenko, M.
    Mahableshwarkar, A. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S263 - S264
  • [22] A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine (Lu AA21004), on Actual Driving and Cognition
    Theunissen, E. L.
    Street, D.
    Hojer, A-M
    Vermeeren, A.
    van Oers, A.
    Ramaekers, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) : 493 - 501
  • [23] 5HT1A AGONIST ACTIVITY AND THE ANTIDEPRESSANT EFFICACY OF LU AA21004
    Mayze, T.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [24] RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS OF LU AA21004
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1114 - 1114
  • [25] The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder
    Florea, I.
    Dragheim, M.
    Loft, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S255 - S256
  • [26] The safety and tolerability of vortioxetine (Lu AA21004) in the treatment of adults with major depressive disorder (MDD): A pooled analysis
    Baldwin, David S.
    Serenko, Michael
    Palo, William
    Lophaven, Soren
    Matz, Jorgen
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 16 - 17
  • [27] Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder
    Baldwin, David S.
    Hansen, Thomas
    Florea, Ioana
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1717 - 1724
  • [28] Drug interactions with vortioxetine, a new multimodal antidepressant
    Spina, Edoardo
    Santoro, Vincenza
    RIVISTA DI PSICHIATRIA, 2015, 50 (05) : 210 - 215
  • [29] Lu AA21004: a novel potential treatment for mood disorders
    Moore, N.
    Bang-Andersen, B.
    Brennum, L.
    Fredriksen, K.
    Hogg, S.
    Mork, A.
    Stensbol, T.
    Zhong, H.
    Sanchez, C.
    Smith, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S321 - S321
  • [30] EFFECT OF FOOD ON THE PHARMACOKINETICS OF LU AA21004 IN HEALTHY VOLUNTEERS
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1115 - 1115
12345